Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Neuralgo-Rheum is an injectable homeopathic combination product formulated primarily for the treatment of nerve pain, soft tissue rheumatism, sciatica, and symptoms associated with disc protrusion. It contains multiple highly diluted botanical and mineral substances, including Causticum, Colchicum autumnale, Colocynthis, Ferrum metallicum, Gnaphalium polycephalum, Lithium benzoicum, Rhus toxicodendron, and Spiraea ulmaria, which are selected according to homeopathic principles to modulate nociceptive signaling and inflammatory responses rather than acting via a defined single molecular target. Marketed by homeopathic manufacturers such as Heel/Medinatura, it is used by integrative and chiropractic practitioners as a non-opioid, non-NSAID option for injection therapy in neuropathic and rheumatic pain, although it is not approved by major regulators as an evidence-based analgesic and its pharmacological mechanism in conventional biomedical terms remains uncharacterized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Neuralgo-Rheum.